Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
47.46 USD | -0.06% | -4.81% | -20.72% |
Evolution of the average Target Price on Apellis Pharmaceuticals, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Apellis Pharmaceuticals, Inc.
Mizuho Securities | |
Wedbush | |
JPMorgan Chase | |
UBS | |
Jefferies & Co. | |
Oppenheimer | |
Needham & Co. | |
Wells Fargo Securities | |
Baird | |
Raymond James | |
Goldman Sachs | |
Citigroup | |
BofA Securities | |
Stifel Nicolaus | |
HC Wainwright | |
Credit Suisse | |
Roth Capital Partners | |
BMO Capital | |
Cowen | |
J.P. Morgan Chase |
EPS Revisions
- Stock Market
- Equities
- APLS Stock
- Consensus Apellis Pharmaceuticals, Inc.